Cite
Herborg F, Jensen KL, Tolstoy S, et al. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease. JCI Insight. 2021;6(18)doi: 10.1172/jci.insight.151496.
Herborg, F., Jensen, K. L., Tolstoy, S., Arends, N. V., Posselt, L. P., Shekar, A., Aguilar, J. I., Lund, V. K., Erreger, K., Rickhag, M., Lycas, M. D., Lonsdale, M. N., Rahbek-Clemmensen, T., Sørensen, A. T., Newman, A. H., Løkkegaard, A., Kjærulff, O., Werge, T., Møller, L. B., Matthies, H. J., Galli, A., Hjermind, L. E., & Gether, U. (2021). Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease. JCI insight, 6(18), . https://doi.org/10.1172/jci.insight.151496
Herborg, Freja, et al. "Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease." JCI insight vol. 6,18 (2021). doi: https://doi.org/10.1172/jci.insight.151496
Herborg F, Jensen KL, Tolstoy S, Arends NV, Posselt LP, Shekar A, Aguilar JI, Lund VK, Erreger K, Rickhag M, Lycas MD, Lonsdale MN, Rahbek-Clemmensen T, Sørensen AT, Newman AH, Løkkegaard A, Kjærulff O, Werge T, Møller LB, Matthies HJ, Galli A, Hjermind LE, Gether U. Identifying dominant-negative actions of a dopamine transporter variant in patients with parkinsonism and neuropsychiatric disease. JCI Insight. 2021 Sep 22;6(18). doi: 10.1172/jci.insight.151496. PMID: 34375312; PMCID: PMC8492322.
Copy
Download .nbib